Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$12.82 - $16.85 $18,332 - $24,095
-1,430 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$16.31 - $28.29 $23,323 - $40,454
1,430 New
1,430 $25,000
Q1 2019

Apr 29, 2019

SELL
$8.0 - $19.66 $800 - $1,966
-100 Closed
0 $0
Q4 2018

Jan 28, 2019

BUY
$8.59 - $18.05 $859 - $1,805
100 New
100 $1,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $272M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.